1993 …2020
If you made any changes in Pure these will be visible here soon.

Research Output 1993 2018

2018

Adjuvant therapy for resected colon cancer 2017, including the IDEA analysis

Tang, M., Price, T. J., Shapiro, J., Gibbs, P., Haller, D. G., Arnold, D., Peeters, M., Segelov, E., Roy, A., Tebbutt, N., Pavlakis, N., Karapetis, C. & Burge, M. 3 Apr 2018 In : Expert Review of Anticancer Therapy. 18, 4, p. 339-349 11 p.

Research output: Contribution to journalArticle

Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM Study

Shapiro, J., Thavaneswaran, S., Underhill, C. R., Robledo, K. P., Karapetis, C. S., Day, F., Nott, L. M., Jefford, M. J., Chantrill, L. A., Pavlakis, N., Tebbutt, N. C., Price, T. J., Khasraw, M., Van Hazel, G. A., Waring, P., Tejpar, S., Simes, R. J. & Segelov, E. 2018 (Accepted/In press) In : Clinical Colorectal Cancer. p. 1-7 7 p.

Research output: Contribution to journalArticle

Open Access

Follow-Up for Resected Gastroenteropancreatic Neuroendocrine Tumours: A Practice Survey of the Commonwealth Neuroendocrine Tumour Collaboration (CommNETS) and the North American Neuroendocrine Tumor Society (NANETS)

Chan, D., Moody, L., Segelov, E., Metz, D., Strosberg, J. R., Pavlakis, N. & Singh, S. Jul 2018 In : Neuroendocrinology. 107, 1, p. 32-41 10 p.

Research output: Contribution to journalArticle

Follow-up recommendations for completely resected gastroenteropancreatic neuroendocrine tumors

Singh, S. , Moody, L. , Chan, D. L. , Metz, D. , Strosberg, J. R. , Asmis, T. , Bailey, D. , Bergsland, E. K. , Brendtro, K. , Carroll, R. , Cleary, S. P. , Griffiths, K. M. , Kong, G. , Law, C. , Lawrence, B. , McEwan, A. , McGregor, C. , Michael, M. , Pasieka, J. , Pavlakis, N. & 4 others Pommier, R. F., Soulen, M. C., Wyld, D. & Segelov, E. 2018 (Accepted/In press) In : JAMA Oncology. p. 1-8 8 p.

Research output: Contribution to journalArticle

Immunohistochemistry testing for mismatch repair deficiency in Stage 2 colon cancer: A cohort study of two cancer centres

Grant, M., Haydon, A., Au, L., Wilkins, S., Oliva, K., Segelov, E., Antill, Y., Carne, P., Ranchod, P., Polglase, A., Farmer, C., Chin, M., Wale, R., Simpson, P., Bell, S., Skinner, S., McMurrick, P. & Shapiro, J. 1 Mar 2018 In : International Journal of Surgery. 51, p. 71-75 5 p.

Research output: Contribution to journalArticle

Influence of population immunosuppression and past vaccination on smallpox reemergence

MacIntyre, C. R., Costantino, V., Chen, X., Segelov, E., Chughtai, A. A., Kelleher, A., Kunasekaran, M. & Lane, J. M. 1 Apr 2018 In : Emerging Infectious Diseases. 24, 4, p. 646-653 8 p.

Research output: Contribution to journalArticle

Long-term Outcomes of Gastroenteropancreatic Neuroendocrine Tumors

Chi, W., Warner, R. R. P., Chan, D. L., Singh, S., Segelov, E., Strosberg, J., Wisnivesky, J. & Kim, M. K. 1 Mar 2018 In : Pancreas. 47, 3, p. 321-325 5 p.

Research output: Contribution to journalArticle

Patients’ preferences for 3 months versus 6 months of adjuvant chemotherapy (ACT) for colon cancer in the SCOT trial: what survival benefits make longer chemotherapy worthwhile?

Segelov, E., Blinman, P., Martin, A., Goldstein, D., Cronk, M., Boadle, D., Tebbutt, N., Paul, J. & Haydon, A. 2018

Research output: Contribution to conferenceAbstract

Recurrence in resected Gastroenteropancreatic Neuroendocrine Tumors

Singh, S., Chan, D., Moody, L., Liu, N., Fischer, H., Austin, P. & Segelov, E. 2018 In : JAMA Oncology. 4, 4, p. 583-585 3 p.

Research output: Contribution to journalLetter

Targeted therapy for metastatic colorectal cancer

Price, T. J., Tang, M., Gibbs, P., Haller, D. G., Peeters, M., Arnold, D., Segelov, E., Roy, A., Tebbutt, N., Pavlakis, N., Karapetis, C., Burge, M. & Shapiro, J. 2018 (Accepted/In press) In : Expert Review of Anticancer Therapy. p. 1-16 16 p.

Research output: Contribution to journalReview Article

The prognostic role of inflammatory markers in patients with metastatic colorectal cancer treated with bevacizumab

Segelov, E., Clarke, S. J., Burge, M. E., Feeney, K. & Gibbs, P. 2018 p. 719

Research output: Contribution to conferenceAbstract

Open Access
2017

Current challenges in optimizing systemic therapy for patients with pancreatic cancer: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty

Segelov, E., Lordick, F., Goldstein, D., Chantrill, L. A., Croagh, D., Lawrence, B., Arnold, D., Chau, I., Obermannova, R. & Price, T. J. 3 Oct 2017 In : Expert Review of Anticancer Therapy. 17, 10, p. 951-964 14 p.

Research output: Contribution to journalReview Article

Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer

Chan, D. L. H., Segelov, E., Wong, R. S. H., Smith, A., Herbertson, R. A., Li, B. T., Tebbutt, N., Price, T. & Pavlakis, N. 27 Jun 2017 In : Cochrane Database of Systematic Reviews. 2017, 6, 178 p., CD007047

Research output: Contribution to journalReview Article

Escalated dose somatostatin analogues (SSAs) in management of neuroendocrine tumors (NETs): A systematic review

Chan, D., Ferone, D., Albertelli, M., Segelov, E. & Singh, S. 2017

Research output: Contribution to conferencePoster

Escalated-dose somatostatin analogues for antiproliferative effect in GEPNETS: a systematic review

Chan, D. L., Ferone, D., Albertelli, M., Pavlakis, N., Segelov, E. & Singh, S. Sep 2017 In : Endocrine. 57, 3, p. 366-375 10 p.

Research output: Contribution to journalArticle

Everolimus in the management of metastatic neuroendocrine tumours

Chan, D. L., Segelov, E. & Singh, S. 1 Jan 2017 In : Therapeutic Advances in Gastroenterology. 10, 1, p. 132-141 10 p.

Research output: Contribution to journalReview Article

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

Wasan, H. S. , Gibbs, P. , Sharma, N. K. , Taieb, J. , Heinemann, V. , Ricke, J. , Peeters, M. , Findlay, M. , Weaver, A. , Mills, J. , Wilson, C. , Adams, R. , Francis, A. , Moschandreas, J. , Virdee, P. S. , Dutton, P. , Love, S. , Gebski, V. , Gray, A. , FOXFIRE trial investigators & 4 others SIRFLOX trial investigators, FOXFIRE-Global trial investigators, van Hazel, G. & Sharma, R. A. 1 Sep 2017 In : The Lancet Oncology. 18, 9, p. 1159-1171 13 p.

Research output: Contribution to journalArticle

Follow-up and recurrence in resected gastroenteropancreatic neuroendocrine tumours: A population-based study

Chan, D., Segelov, E., Moody, L., Liu, N., Fischer, H., Austin, P. & Singh, S. 2017 1 p.

Research output: Contribution to conferenceAbstract

Prevalence and predictors of unsatisfactory anal cytology tests in a cohort of gay and bisexual men in Sydney, Australia: Baseline findings from the Study of the Prevention of Anal Cancer (SPANC)

Templeton, D. J., Roberts, J. M., Poynten, I. M., Law, C., Hillman, R. J., Farnsworth, A., Fairley, C. K., Tabrizi, S. N., Garland, S. M., Grulich, A. E., Jin, F. & On behalf of the SPANC Study Team 2017 In : European Journal of Cancer Prevention. 26, 3, p. 212-216 5 p.

Research output: Contribution to journalArticle

Randomized evaluation of cognitive-behavioral therapy and graded exercise therapy for post-cancer fatigue

Sandler, C. X., Goldstein, D. A., Horsfield, S., Bennett, B. K., Friedlander, M., Bastick, P. A., Lewis, C. R., Segelov, E., Boyle, F. M., Chin, M. T. M., Webber, K., Barry, B. K. & Lloyd, A. R. Jul 2017 In : Journal of Pain and Symptom Management. 54, 1, p. 74-84 11 p.

Research output: Contribution to journalArticle

The North American Neuroendocrine Tumor Society consensus guidelines for surveillance and medical management of midgut neuroendocrine tumors

Strosberg, J. R., Halfdanarson, T. R., Bellizzi, A. M., Chan, J. A., Dillon, J. S., Heaney, A. P., Kunz, P. L., O'Dorisio, T. M., Salem, R., Segelov, E., Howe, J. R., Pommier, R. F., Brendtro, K., Bashir, M. A., Singh, S., Soulen, M. C., Tang, L., Zacks, J. S., Yao, J. C. & Bergsland, E. K. 2017 In : Pancreas. 46, 6, p. 707-714 8 p.

Research output: Contribution to journalArticle

Therapy for Metastatic Disease: Ileum

Segelov, E., Singh, S. & Chan, D. 7 Sep 2017 Neuroendocrine Tumors in Real Life. Springer, p. 305-323

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)

Open Access

Uncommon Anal Neoplasms

Roy, A. C., Wattchow, D., Astill, D., Singh, S., Pendlebury, S., Gormly, K. & Segelov, E. 1 Jan 2017 In : Surgical Oncology Clinics of North America. 26, 1, p. 143-161 19 p.

Research output: Contribution to journalReview Article

2016

A composite cytology-histology endpoint allows a more accurate estimate of anal high-grade squamous intraepithelial lesion prevalence

Machalek, D. A., Poynten, I. M., Jin, F., Hillman, R. J., Templeton, D. J., Law, C., Roberts, J. M., Tabrizi, S. N., Farnsworth, A., Fairley, C. K., Grulich, A. E. & SPANC Study Team 1 Jul 2016 In : Cancer Epidemiology Biomarkers and Prevention. 25, 7, p. 1134-1143 10 p.

Research output: Contribution to journalArticle

Open Access

Adjuvant anti-VEGF therapy for overall survival and relapse-free survival in patients with resected non-metastatic colorectal cancer

Chan, D. L. H., Espinoza, D., Chan, J., Lee, A., Faisal, W., Segelov, E. & Pavlakis, N. 7 Dec 2016 In : Cochrane Database of Systematic Reviews. 2016, 12, CD012460

Research output: Contribution to journalArticle

Adjuvant capecitabine plus bevacizumab versus capecitabine alone in patients with colorectal cancer (QUASAR 2): an open-label, randomised phase 3 trial

Kerr, R. S., Love, S., Segelov, E., Johnstone, E., Falcon, B., Hewett, P., Weaver, A., Church, D., Scudder, C., Pearson, S., Julier, P., Pezzella, F., Tomlinson, I., Domingo, E. & Kerr, D. J. 1 Nov 2016 In : Lancet Oncology. 17, 11, p. 1543-1557 15 p.

Research output: Contribution to journalArticle

ASCOLT: Aspirin for Dukes B and High Risk Dukes C Colorectal Cancers

Segelov, E., Ashgari, R., Simes, R. J., Yip, S., Coote, A., Friend, C., Aiken, C., Chia Whay, J. & Jeffery, M. 2016 p. 167-8

Research output: Contribution to conferenceAbstract

Availability and Utility of Functional Imaging (FI) and Peptide Receptor Radionuclide Therapy (PRRT) in the CommNETS Collaboration (Australia, Canada and New Zealand)

Segelov, E., Chan, B. A., Sim, H. W., Ravikumar, A., Bailey, D., Chan, D., McEwan, A., Pavlakis, N., Singh, S., Roach, P. & Wyld, D. 2016

Research output: Contribution to conferenceAbstract

Open Access

CommNETS: Formation of an International Commonwealth countries NET partnership

Singh, S., Lawrence, B., Chan, D., Pavlakis, N. & Segelov, E. 2016 p. 120 1 p.

Research output: Contribution to conferencePoster

CpG methylation analysis of HPV16 in laser capture microdissected archival tissue and whole tissue sections from high grade anal squamous intraepithelial lesions: A potential disease biomarker

Molano, M., Tabrizi, S. N., Garland, S. M., Roberts, J. M., MacHalek, D. A., Phillips, S., Chandler, D., Hillman, R. J., Grulich, A. E., Jin, F., Poynten, I. M., Templeton, D. J., Cornall, A. M. & SPANC Study Team 1 Aug 2016 In : PLoS ONE. 11, 8, e0160673

Research output: Contribution to journalArticle

Open Access
File

Current trials in Neuroendocrine Tumours: A systematic review

Chan, D. L., Segelov, E., Millican, J., Singh, S. & Pavlakis, N. 2016 p. 115 1 p.

Research output: Contribution to conferenceAbstract

Diagnosis and management of gastrointestinal neuroendocrine tumors: An evidence-based Canadian consensus

Singh, S., Asa, S. L., Dey, C., Kennecke, H., Laidley, D., Law, C., Asmis, T., Chan, D., Ezzat, S., Goodwin, R., Mete, O., Pasieka, J., Rivera, J., Wong, R., Segelov, E. & Rayson, D. 1 Jun 2016 In : Cancer Treatment Reviews. 47, p. 32-45 14 p.

Research output: Contribution to journalReview Article

ICECREAM: Randomised phase II study of cetuximab alone or in combination with irinotecan in patients with metastatic colorectal cancer with either KRAS, NRAS, BRAF and PI3KCA wild type, or G13D mutated tumours

Segelov, E. , Waring, P. , Desai, J. , Wilson, K. , Gebski, V. , Thavaneswaran, S. , Elez, E. , Underhill, C. , Pavlakis, N. , Chantrill, L. , Nott, L. , Jefford, M. , Khasraw, M. , Day, F. , Wasan, H. , Ciardiello, F. , Karapetis, C. , Joubert, W. , Hazel, G. , Haydon, A. & 4 others Price, T., Tejpar, S., Tebbutt, N. & Shapiro, J. 31 May 2016 In : BMC Cancer. 16, 1, 339

Research output: Contribution to journalArticle

Open Access
File
Open Access
File

Indications for, and impact of oncotype DX on adjuvant treatment recommendations when third party funding is unavailable

Chin-Lenn, L., Segelov, E., De Boer, R., Marx, G. M., Hughes, T., McCarthy, N., White, S. C., Foo, S. L., Rutovitz, J., Della-Fiorentina, S., Jennens, R. R., Antill, Y., Tsoi, D., Cronk, M., Lombard, J. M., Kiely, B., Chirgwin, J. & Bruce Mann, G. 2016

Research output: Contribution to conferencePoster

JRK is a positive regulator of β-catenin transcriptional activity commonly overexpressed in colon, breast and ovarian cancer

Pangon, L., Ng, I., Giry-Laterriere, M., Currey, N., Morgan, A., Benthani, F., Tran, P. N., Al-Sohaily, S., Segelov, E., Parker, B. L., Cowley, M. J., Wright, D. C., St Heaps, L., Carey, L., Rooman, I. & Kohonen-Corish, M. R. J. 2 Jun 2016 In : Oncogene. 35, 22, p. 2834-2841 8 p.

Research output: Contribution to journalArticle

Optimal follow-up strategy for resected neuroendocrine tumours: a systematic review

Patel, D., Chan, D., Moody, L., Metz, D., Strosberg, J. R., Segelov, E. & Singh, S. 2016

Research output: Contribution to conferencePoster

Open Access

Pancreatic neuroendocrine tumours - A rare pancreatic tumour

Chan, D. L., Pavlakis, N., Roach, P., Bailey, D., Arena, J. & Segelov, E. 1 Mar 2016 In : Cancer Forum. 40, 1, p. 34-39 6 p.

Research output: Contribution to journalReview Article

Prevalence and risk factors associated with high-grade anal squamous intraepithelial lesions (HSIL)-AIN2 and HSIL-AIN3 in homosexual men

Machalek, D. A., Jin, F., Poynten, I. M., Hillman, R. J., Templeton, D. J., Law, C., Roberts, J. M., Tabrizi, S. N., Garland, S. M., Farnsworth, A., Fairley, C. K., Grulich, A. E. & the SPANC study team 1 Dec 2016 In : Papillomavirus Research. 2, p. 97-105 9 p.

Research output: Contribution to journalArticle

Open Access

Response to cetuximab with or without irinotecan in patients with refractory metastatic colorectal cancer harboring the KRAS G13D mutation: Australasian gastro-intestinal trials group ICECREAM study

Segelov, E. , Thavaneswaran, S. , Waring, P. M. , Desai, J. , Robledo, K. P. , Gebski, V. J. , Elez, E. , Nott, L. M. , Karapetis, C. S. , Lunke, S. , Chantrill, L. A. , Pavlakis, N. , Khasraw, M. , Underhill, C. , Ciardiello, F. , Jefford, M. , Wasan, H. , Haydon, A. , Price, T. J. , Van Hazel, G. & 3 others Wilson, K., Simes, J. & Shapiro, J. D. 1 Jul 2016 In : Journal of Clinical Oncology. 34, 19, p. 2258-2264 7 p.

Research output: Contribution to journalArticle

TACTIC: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancer

Ferraro, D., Goldstein, D., O’Connell, R. L., Zalcberg, J. R., Sjoquist, K. M., Tebbutt, N. C., Grimison, P., McLachlan, S., Lipton, L. L., Vasey, P., Gebski, V. J., Aiken, C., Cronk, M., Ng, S., Karapetis, C. S., Shannon, J. & the Australasian Gastro-Intestinal Trials Group 1 Aug 2016 In : Cancer Chemotherapy and Pharmacology. 78, 2, p. 361-367 7 p.

Research output: Contribution to journalArticle

The value of a transformation zone component in anal cytology to detect HSIL

Roberts, J. M., Jin, F., Thurloe, J. K., Ekman, D., Adams, M. K., McDonald, R. L., Biro, C., Poynten, I. M., Grulich, A. E., Farnsworth, A. & The Study of the Prevention of Anal Cancer (SPANC) Study Team 1 Aug 2016 In : Cancer Cytopathology. 124, 8, p. 596-601 6 p.

Research output: Contribution to journalArticle

Update on optimal treatment for metastatic colorectal cancer from the ACTG/AGITG expert meeting: ECCO 2015

Price, T. J., Thavaneswaran, S., Burge, M., Segelov, E., Haller, D. G., Punt, C. J. A., Arnold, D., Karapetis, C. S., Tebbutt, N. C., Pavlakis, N., Gibbs, P. & Shapiro, J. D. 3 May 2016 In : Expert Review of Anticancer Therapy. 16, 5, p. 557-571 15 p.

Research output: Contribution to journalReview Article

Use of chemotherapy and mismatch repair deficiency testing in resected stage II colon cancer

Au, L., Grant, M., Haydon, A., Oliva, K., Wilkins, S. T., Segelov, E., Antill, Y., Peter, C., Ranchod, P., Chin, M., Skinner, S., Wale, R., McMurrick, P. & Shapiro, J. 2016

Research output: Contribution to conferencePoster

Open Access